Cycling Deep Brain Stimulation on Parkinson's Disease Gait
DBS
Effects of Cycling Deep Brain Stimulation on Parkinson's Disease Gait
1 other identifier
interventional
30
1 country
1
Brief Summary
Our hypothesis is that cycling DBS stimulation would be superior or non-inferior to regular DBS stimulation in Parkinson's disease patients with gait impairment. The objective of this study is compare gait disorders in patients with Parkinson's disease and DBS in 4 different scenarios: 1) regular continuous high frequency (\>130Hz) stimulation, 2) cycling high frequency (\>130Hz) stimulation (40sec on, 2sec off), 3) low-frequency (80Hz) continuous stimulation and 4) cycling low frequency (80Hz) stimulation (40sec on, 2sec off)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable parkinson-disease
Started Jun 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 25, 2020
CompletedFirst Posted
Study publicly available on registry
May 29, 2020
CompletedStudy Start
First participant enrolled
June 19, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 29, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 29, 2021
CompletedJune 23, 2020
June 1, 2020
11 months
May 25, 2020
June 19, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Change in the part II of the Unified Parkinson's disease rating scale
The part II of the Unified Parkinson's disease rating scale (UPDRS II) is a self-reportable questionnaire consisting of 13 items that measure functionality (motor experiences of daily living). Scores vary from 0 - 52. Higher scores mean a worse outcome.
Baseline + after 2 weeks + after 4 weeks + after 6 weeks
Change in the New Freezing of Gait Questionnaire
The New Freezing of Gait Questionnaire (NFOG-Q) is a self-reportable questionnaire consisting of 9 items that measure freezing of gait (FOG). Scores vary from 0 - 28. Higher scores mean a worse outcome.
Baseline + after 2 weeks + after 4 weeks + after 6 weeks
Secondary Outcomes (4)
Change in Falls Efficacy Scale
Baseline + after 2 weeks + after 4 weeks + after 6 weeks
Change in The Parkinson's Disease Questionnaire (PDQ-39)
Baseline + after 2 weeks + after 4 weeks + after 6 weeks
Change in Activities-Specific Balance Confidence Scale (ABC scale)
Baseline + after 2 weeks + after 4 weeks + after 6 weeks
Number of falls
Baseline + after 2 weeks + after 4 weeks + after 6 weeks
Study Arms (4)
Regular Continuous High Frequency
NO INTERVENTIONPatient remains 2 weeks in the currently chosen stimulation protocol.
Cycling High Frequency
EXPERIMENTALPatient is stimulated with the same polarity, voltage/current, pulse width and frequency as the currently chosen stimulation protocol, but with cycling stimulation: 40sec On - 02 sec OFF
Continuous Low Frequency
EXPERIMENTALPatient is stimulated with the same polarity and pulse width as the currently chosen stimulation protocol, but with low frequency (80Hz). Voltage/current will be adjusted to maintain TEED similar to that on the regular stimulation protocol.
Cycling Low Frequency
EXPERIMENTALPatient is stimulated with the same polarity and pulse width as the currently chosen stimulation protocol, but with low frequency (80Hz) and cycling stimulation: 40sec On - 02 sec OFF. Voltage/current will be adjusted to maintain TEED similar to that on the regular stimulation protocol.
Interventions
Deep Brain Stimulation applied in cycling - periods of stimulation ON intercalated with periods of stimulation OFF
Eligibility Criteria
You may qualify if:
- Diagnosis of idiopathic Parkinson's disease
- Currently receiving Deep Brain Stimulation as a Parkinson's disease treatment
- Hoehn \& Yahr stage between 2-4 during off-medication
- Underlying gait disorders despite optimal medical and stimulation treatment: score over or equal to 1 in the subitem 2.12 of the MDS-UPDRS scale
- Willingness to comply with all study procedures
You may not qualify if:
- Active moderate/severe psychiatric condition
- Active infection or other uncontrolled moderate/grave comorbidities
- Treatment with experimental drug
- Pregnancy or breast-feeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital das Clínicas da Faculdade de Medicina da USP
São Paulo, São Paulo, 05403000, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rubens G Cury, MD, PhD
University of Sao Paulo General Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 25, 2020
First Posted
May 29, 2020
Study Start
June 19, 2020
Primary Completion
May 29, 2021
Study Completion
December 29, 2021
Last Updated
June 23, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Data will be made available indefinitely upon reasonable request from other authors
- Access Criteria
- Investigator Rubens Cury will analyse request and decide upon reasonability
all IPD that underlie results in a publication